Literature DB >> 11442218

Short report: IgG1/IgG3 antibody responses to various analogs of recombinant ypfmsp119--a study in immune adults living in areas of Plasmodium falciparum transmission.

T O Diallo1, A Spiegel, A Diouf, R Perraut, D C Kaslow, O Garraud.   

Abstract

To further characterize protective-type (IgG1/IgG3) antibody responses to Plasmodium falciparum blood stage in putatively immune individuals' plasma, we have tested for various analogs of the 19 kDa C-terminus of the MSP1 antigen obtained as secreted recombinant proteins from Saccharomyces cerevisiae. One of four proteins was then identified on the basis of consistent IgG3, along with less variable IgG1 recognition. This protein has thus been selected for further functional assays of IgG1/IgG3 antibodies.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11442218     DOI： 10.4269/ajtmh.2001.64.204

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  8 in total

1.  Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria.

Authors:  J Eric Tongren; Christopher J Drakeley; Suzanna L R McDonald; Hugh G Reyburn; Alphaxard Manjurano; Watoky M M Nkya; Martha M Lemnge; Channe D Gowda; Jim E Todd; Patrick H Corran; Eleanor M Riley
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Total immunoglobulin G and IgG1 subclass levels specific for the MSP-1(19) of Plasmodium falciparum are different in individuals with either processing-inhibitory, blocking or neutral antibodies.

Authors:  Y O Omosun; S Adoro; C I Anumudu; A Odaibo; A A Holder; M Nwagwu; R I Nwuba
Journal:  Afr Health Sci       Date:  2010-06       Impact factor: 0.927

3.  Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model.

Authors:  Olivier Garraud; Ronald Perraut; Ababacar Diouf; Wilfrid S Nambei; Adama Tall; André Spiegel; Shirley Longacre; David C Kaslow; Hélène Jouin; Denise Mattei; Gina M Engler; Thomas B Nutman; Eleanor M Riley; Odile Mercereau-Puijalon
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships.

Authors:  Karen M Walker; Shinji Okitsu; David W Porter; Christopher Duncan; Mario Amacker; Gerd Pluschke; David R Cavanagh; Adrian V S Hill; Stephen M Todryk
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

5.  Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.

Authors:  Sedigheh Zakeri; Akram A Mehrizi; Samaneh Zoghi; Navid D Djadid
Journal:  Malar J       Date:  2010-09-16       Impact factor: 2.979

Review 6.  Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

Authors:  S L Takala; C V Plowe
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

7.  Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.

Authors:  Shannon L Takala; Drissa Coulibaly; Mahamadou A Thera; Alassane Dicko; David L Smith; Ando B Guindo; Abdoulaye K Kone; Karim Traore; Amed Ouattara; Abdoulaye A Djimde; Paul S Sehdev; Kirsten E Lyke; Dapa A Diallo; Ogobara K Doumbo; Christopher V Plowe
Journal:  PLoS Med       Date:  2007-03       Impact factor: 11.069

8.  Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.

Authors:  Anitha Mamillapalli; Sujatha Sunil; Suraksha S Diwan; Surya K Sharma; Prajesh K Tyagi; Tridibes Adak; Hema Joshi; Pawan Malhotra
Journal:  Malar J       Date:  2007-07-20       Impact factor: 2.979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.